Skip to main content
. 2021 Mar 11;9(4):2300–2304. doi: 10.1002/ccr3.4019

TABLE 1.

Summary of the existing case reports on sudden sensorineural hearing loss in SARS‐CoV‐2‐positive patients

N Article (2020)

Author

(reference)

Sex

Age

(years)

Laterality

of SSNHL

4‐frequency PTA (dB) Treatment Outcome after reported FU
1 May Karimi (3) M 22 Left 0 ‐ 0 – 30 ‐ 40 Unknown Unknown
2 May Karimi (3) F 40 Right 50 ‐ 60 ‐ 60 ‐ 60 Unknown Unknown
3 May Karimi (3) F 23 Left 30 ‐ 35 ‐ 35 ‐ 40 Unknown Unknown
4 June Degen (4) M 60 Bilateral Unknown

Urgent cochlear implantation (Right),

3 IT injections (Left)

Unknown
5 June Kilic (5) M 29 Right 50 ‐ 40 ‐ 20 ‐ 10 Hydroxychloroquine Complete hearing recovery
6 September Lang (6) F 30 Right 15 ‐ 10 ‐ 95 ‐ 80 Oral prednisolone No significant improvement
7 September Koumpa (7) M 45 Left Unknown Oral prednisolone and 3 IT injections Partial improvement
8 September Lamounier (8) F 67 Right 60 ‐ 85 ‐ 75 ‐ 75 Oral prednisolone and 5 IT injections Isolated recovery at 250Hz

The audiometric data of the hearing loss at onset are reported as 4‐frequency pure‐tone average at respectively 500Hz ‐ 1000Hz ‐ 2000Hz ‐ 3000 or 4000Hz frequencies.

Abbreviations: dB, Decibels; F, Female; FU, Follow‐up period; Hz, Hertz; IT, Intratympanic corticoid; M, Male; N, Number; PTA, pure‐tone average; SNHL, Sensorineural hearing loss.